Vimarsana
Biggest News Aggregation in the World

Jim Januzzi News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Jim Januzzi. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Jim Januzzi Today - Breaking & Trending Today

The Pathophysiology of Obstructive Hypertrophic Cardiomyopathy (oHCM) - Vimarsana News

The Pathophysiology of Obstructive Hypertrophic Cardiomyopathy (oHCM)

Andrew Wang, MD, outlines the epidemiology of obstructive hypertrophic cardiomyopathy (oHCM), and Milind Desai, MD, MBA, reviews the etiology of the condition.

Clinical Pearls for the Treatment of Heart Failure - Vimarsana News

Clinical Pearls for the Treatment of Heart Failure

Drs James Januzzi, Javed Butler, Robert Mentz, and Muthiah Vaduganathan share practice pearls for treating patients with heart failure, focusing on the future of treatment.

Biofourmis Selected by ACC as Exclusive Virtual Care Platform to Drive TRANSFORM(3) Study - Vimarsana News

Biofourmis Selected by ACC as Exclusive Virtual Care Platform to Drive TRANSFORM(3) Study

Biofourmis Care, a comprehensive care management platform including virtual multidisciplinary care teams, to be evaluated against in-person care among underserved patients with chronic cardiovascular conditions

Biofourmis Selected by American College of Cardiology as Exclusive Virtual Care Platform to Drive TRANSFORM3 Study Focused on Closing Practice Gaps for Heart Conditions - Vimarsana News

Biofourmis Selected by American College of Cardiology as Exclusive Virtual Care Platform to Drive TRANSFORM3 Study Focused on Closing Practice Gaps for Heart Conditions

/PRNewswire/ -- Biofourmis, a Boston-based global leader in virtual care and digital medicine, announced today that its Biofourmis Care solution has been...

Clinical Challenges: Cardiac Conditions of COVID Long-Haulers - Vimarsana News

Clinical Challenges: Cardiac Conditions of COVID Long-Haulers

Do COVID survivors with cardiac conditions need special treatment and monitoring?